Hans Basun

17.9k total citations · 1 hit paper
133 papers, 7.4k citations indexed

About

Hans Basun is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Hans Basun has authored 133 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Physiology, 56 papers in Psychiatry and Mental health and 19 papers in Molecular Biology. Recurrent topics in Hans Basun's work include Alzheimer's disease research and treatments (70 papers), Dementia and Cognitive Impairment Research (53 papers) and Fatty Acid Research and Health (17 papers). Hans Basun is often cited by papers focused on Alzheimer's disease research and treatments (70 papers), Dementia and Cognitive Impairment Research (53 papers) and Fatty Acid Research and Health (17 papers). Hans Basun collaborates with scholars based in Sweden, United States and United Kingdom. Hans Basun's co-authors include Lars Lannfelt, Lars‐Olof Wahlund, Bengt Winblad, Tommy Cederholm, Gerd Faxén Irving, Maria Eriksdotter, Jan Palmblad, Yvonne Freund‐Levi, Inger Vedin and Ove Almkvist and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hans Basun

131 papers receiving 7.1k citations

Hit Papers

ω-3 Fatty Acid Treatment in 174 Patients With Mild to Mod... 2006 2026 2012 2019 2006 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Basun Sweden 50 4.2k 2.1k 1.6k 1.2k 1.1k 133 7.4k
Vincenzo Solfrizzi Italy 58 4.7k 1.1× 2.7k 1.3× 1.3k 0.8× 813 0.7× 1.3k 1.3× 213 10.2k
Ming‐Xin Tang United States 43 4.1k 1.0× 3.0k 1.5× 1.7k 1.1× 457 0.4× 1.1k 1.1× 75 10.0k
Davide Seripa Italy 53 3.8k 0.9× 2.1k 1.0× 1.7k 1.1× 424 0.4× 1.0k 1.0× 225 9.6k
Umberto Senin Italy 48 2.4k 0.6× 1.1k 0.5× 2.2k 1.4× 1.1k 0.9× 735 0.7× 165 8.3k
Bruno P. Imbimbo Italy 54 4.5k 1.1× 1.4k 0.7× 2.0k 1.3× 379 0.3× 1.3k 1.2× 276 10.1k
Christiane Reitz United States 40 3.7k 0.9× 2.4k 1.1× 1.9k 1.2× 295 0.2× 1.3k 1.2× 113 8.1k
Judes Poirier Canada 48 5.1k 1.2× 1.4k 0.7× 2.8k 1.7× 332 0.3× 1.3k 1.3× 170 8.9k
Elizabeth H. Corder United States 28 6.7k 1.6× 2.9k 1.4× 3.6k 2.3× 352 0.3× 1.5k 1.4× 59 11.3k
J. L. Haines United States 6 4.7k 1.1× 1.8k 0.9× 2.5k 1.5× 244 0.2× 1.0k 1.0× 8 7.3k
Alina Solomon Finland 45 2.9k 0.7× 2.6k 1.3× 1.2k 0.8× 279 0.2× 927 0.9× 174 7.5k

Countries citing papers authored by Hans Basun

Since Specialization
Citations

This map shows the geographic impact of Hans Basun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Basun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Basun more than expected).

Fields of papers citing papers by Hans Basun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Basun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Basun. The network helps show where Hans Basun may publish in the future.

Co-authorship network of co-authors of Hans Basun

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Basun. A scholar is included among the top collaborators of Hans Basun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Basun. Hans Basun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Logovinsky, Veronika, Andrew Satlin, Robert Lai, et al.. (2016). Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody. Alzheimer s Research & Therapy. 8(1). 14–14. 212 indexed citations
2.
Vedin, Inger, Tommy Cederholm, Hans Basun, et al.. (2012). Effects of a DHA rich omega-3 fatty acid supplementation for Alzheimer disease patients on fatty acid composition in cerebrospinal fluid, disease biomarkers and cognition : The OmegAD study. Journal of Molecular Neuroscience. 48. 1 indexed citations
3.
Vedin, Inger, Tommy Cederholm, Yvonne Freund‐Levi, et al.. (2012). Effects of DHA- Rich n-3 Fatty Acid Supplementation on Gene Expression in Blood Mononuclear Leukocytes: The OmegAD Study. PLoS ONE. 7(4). e35425–e35425. 69 indexed citations
4.
Hampel, Harald, Michael Ewers, Katharina Bürger, et al.. (2009). Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.. PubMed. 70(6). 922–31. 252 indexed citations
5.
Vedin, Inger, Tommy Cederholm, Yvonne Freund‐Levi, et al.. (2009). Reduced prostaglandin F2α release from blood mononuclear leukocytes after oral supplementation of ω3 fatty acids: the OmegAD study. Journal of Lipid Research. 51(5). 1179–1185. 43 indexed citations
6.
Vedin, Inger, Tommy Cederholm, Yvonne Freund‐Levi, et al.. (2008). Effects of docosahexaenoic acid–rich n−3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study. American Journal of Clinical Nutrition. 87(6). 1616–1622. 137 indexed citations
7.
Freund‐Levi, Yvonne, Hans Basun, Tommy Cederholm, et al.. (2007). Omega‐3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. International Journal of Geriatric Psychiatry. 23(2). 161–169. 147 indexed citations
8.
Kilander, Lena, et al.. (2007). Reduction of Phosphorylated Tau during Memantine Treatment of Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 24(4). 247–252. 41 indexed citations
9.
Grote, Ludger, et al.. (2005). A randomized placebo‐controlled trial of an NMDA receptor antagonist in sleep‐disordered breathing. Journal of Sleep Research. 14(2). 149–155. 14 indexed citations
10.
Karlberg, Bo, et al.. (2005). Porous graphitic carbon chromatography–tandem mass spectrometry for the study of isoprostanes in human cerebrospinal fluid. Journal of Chromatography B. 827(1). 39–43. 11 indexed citations
11.
Basun, Hans, et al.. (2003). Extended investigation of tau and mutation screening of other candidate genes on chromosome 17q21 in a Swedish FTDP‐17 family. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 121B(1). 112–118. 16 indexed citations
12.
Diener, Hans‐Christoph, et al.. (2002). Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. Journal of Neurology. 249(5). 561–568. 29 indexed citations
13.
Basun, Hans, Charlotte Forsell, Karin Axelman, et al.. (1999). Tau gene polymorphisms and apolipoprotein E ε4 may interact to increase risk for Alzheimer’s disease. Neuroscience Letters. 277(1). 29–32. 54 indexed citations
14.
Axelman, Karin, Hans Basun, & Lars Lannfelt. (1998). Apolipoprotein E and α<sub>1</sub>-Antichymotrypsin Genotypes and Age of Onset of Familial Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 10(1). 1–5. 4 indexed citations
15.
Basun, Hans, Ove Almkvist, Karin Axelman, et al.. (1997). Clinical Characteristics of a Chromosome 17--Linked Rapidly Progressive Familial Frontotemporal Dementia. Archives of Neurology. 54(5). 539–544. 49 indexed citations
16.
Shigeta, Masahiro, et al.. (1995). EEG in successful aging. Electroencephalography and Clinical Neurophysiology. 95(2). 77–83. 7 indexed citations
17.
Jensen, Malene, Hans Basun, & Lars Lannfelt. (1995). Increased cerebrospinal fluid tau in patients with Alzheimer's disease. Neuroscience Letters. 186(2-3). 189–191. 109 indexed citations
18.
Basun, Hans, Laura Fratiglioni, & Bengt Winblad. (1994). Cobalamin Levels Are Not Reduced in Alzheimer's Disease: Results from a Population‐Based Study. Journal of the American Geriatrics Society. 42(2). 132–136. 53 indexed citations
19.
Almkvist, Ove, Lars Bäckman, Hans Basun, & Lars‐Olof Wahlund. (1993). Patterns of Neuropsychological Performance in Alzheimer's Disease and Vascular Dementia. Cortex. 29(4). 661–673. 58 indexed citations
20.
Basun, Hans, Lars Forssell, Ove Almkvist, et al.. (1990). Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer's disease and healthy control subjects. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 2(4). 295–304. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026